BNP Paribas, SBI Group, Siam Commercial Bank, GV and Rakuten are set to exit the cross-border payment platform in a $963m acquisition by Visa.

The Corteva, Novartis, AbbVie and Heritage Medical Systems-backed cancer therapy developer priced a $304m initial public offering at the top of its range.

Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.

Nan Fung and Lam Research are set to exit the DNA sequencing technology developer in an $800m acquisition by market peer Pacific Biosciences.

Telefónica-backed addiction treatment app developer Quit Genius raised $64m while oral care product maker NYSCPS received almost as much in a round featuring ByteDance.

Wipro has made a 4.5 times return on its $4.2m investment in the cyber threat intelligence provider, which has been acquired by Rapid7.

Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.

Greenhouse gas monitor GHGSat boosted a Schlumberger-backed round to $45m while Toyota’s Woven Planet subsidiary is buying spatial intelligence software developer Carmera.

University and diversity-focused recruitment group Yello is merging with its corporate-backed counterpart in a bid to drive DEI hiring strategy.

The price Eli Lilly is paying for protein drug developer and portfolio company Protomer could potentially top $1bn dependent on milestone payments.